메뉴 건너뛰기




Volumn 20, Issue 5, 2010, Pages 1013-1025

Retrospective robustness of the continual reassessment method

Author keywords

Continual reassessment method; Dose finding; Phase I design; Robustness; Sensitivity; Toxicity

Indexed keywords

ARTICLE; CONTINUAL REASSESSMENT METHOD; DOSE CALCULATION; MAXIMUM TOLERATED DOSE; PRIORITY JOURNAL; RELIABILITY; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; STUDY DESIGN; TASK PERFORMANCE;

EID: 77955862482     PISSN: 10543406     EISSN: 15205711     Source Type: Journal    
DOI: 10.1080/10543400903315732     Document Type: Article
Times cited : (23)

References (16)
  • 1
    • 0032581450 scopus 로고    scopus 로고
    • An evaluation of phase i cancer clinical trial designs
    • Ahn, C. (1998). An evaluation of phase I cancer clinical trial designs. Statist. Med. 17:1537-1549.
    • (1998) Statist. Med. , vol.17 , pp. 1537-1549
    • Ahn, C.1
  • 2
    • 0031920799 scopus 로고    scopus 로고
    • Cancer phase I clinical trials: Efficient dose escalation with overdose control
    • DOI 10.1002/(SICI)1097-0258(19980530)17:10<1103::AID-SIM793>3.0. CO;2-9
    • Babb, J., Rogatko, A., Zacks, S. (1998). Cancer phase I clinical trials: efficient dose escalation with overdose control. Statist. Med. 17(10):1103-1120. (Pubitemid 28221028)
    • (1998) Statistics in Medicine , vol.17 , Issue.10 , pp. 1103-1120
    • Babb, J.1    Rogatko, A.2    Zacks, S.3
  • 3
    • 0036712359 scopus 로고    scopus 로고
    • A simple technique to evaluate model sensitivity in the continual reassessment method
    • Cheung, Y. K., Chappell, R. (2002). A simple technique to evaluate model sensitivity in the continual reassessment method. Biometrics 58(3):671-674.
    • (2002) Biometrics , vol.58 , Issue.3 , pp. 671-674
    • Cheung, Y.K.1    Chappell, R.2
  • 4
    • 0027319907 scopus 로고
    • The continual reassessment method in cancer phase i clinical trials: A simulation study
    • Chevret, S. (1993). The continual reassessment method in cancer phase I clinical trials: A simulation study. Statist. Med. 12:1093-1108.
    • (1993) Statist. Med. , vol.12 , pp. 1093-1108
    • Chevret, S.1
  • 5
    • 0028060511 scopus 로고
    • Practical modifications of the continual reassessment method for phase i cancer clinical trials
    • Faries, D. (1994). Practical modifications of the continual reassessment method for phase I cancer clinical trials. J. Biopharm. Statist. 4(2):147-164.
    • (1994) J. Biopharm. Statist. , vol.4 , Issue.2 , pp. 147-164
    • Faries, D.1
  • 7
    • 67649321803 scopus 로고    scopus 로고
    • Model calibration in the continual reassessment method
    • Lee, S. M., Cheung, Y. K. (2009). Model calibration in the continual reassessment method. Clin. Trials 6(3):227-238.
    • (2009) Clin. Trials , vol.6 , Issue.3 , pp. 227-238
    • Lee, S.M.1    Cheung, Y.K.2
  • 9
    • 0033619523 scopus 로고    scopus 로고
    • Another look at two phase i clinical trial designs
    • O'Quigley, J. (1999). Another look at two phase I clinical trial designs. Statist. Med. 18(20):2683-2690.
    • (1999) Statist. Med. , vol.18 , Issue.20 , pp. 2683-2690
    • O'Quigley, J.1
  • 10
    • 27744594554 scopus 로고    scopus 로고
    • Retrospective analysis of sequential dose-finding designs
    • O'Quigley, J. (2005). Retrospective analysis of sequential dose-finding designs. Biometrics 61(3):749-756.
    • (2005) Biometrics , vol.61 , Issue.3 , pp. 749-756
    • O'Quigley, J.1
  • 11
    • 0029938415 scopus 로고    scopus 로고
    • Continual reassessment method: A likelihood approach
    • O'Quigley, J., Shen, L. Z. (1996). Continual reassessment method: a likelihood approach. Biometrics 52(2):673-684.
    • (1996) Biometrics , vol.52 , Issue.2 , pp. 673-684
    • O'Quigley, J.1    Shen, L.Z.2
  • 12
    • 33644840022 scopus 로고    scopus 로고
    • Experimental designs for phase i and phase I/II dose-finding studies
    • O'Quigley, J., Zohar, S. (2006). Experimental designs for phase I and phase I/II dose-finding studies. Br. J. Cancer 94(5):609-613.
    • (2006) Br. J. Cancer , vol.94 , Issue.5 , pp. 609-613
    • O'Quigley, J.1    Zohar, S.2
  • 13
    • 1142304984 scopus 로고    scopus 로고
    • Non-parametric optimal design in dose finding studies
    • O'Quigley, J., Paoletti, X., Maccario, J. (2002). Non-parametric optimal design in dose finding studies. Biostatistics 3:51-56.
    • (2002) Biostatistics , vol.3 , pp. 51-56
    • O'Quigley, J.1    Paoletti, X.2    MacCario, J.3
  • 14
    • 0025148278 scopus 로고
    • Continual reassessment method: A practical design for phase 1 clinical trials in cancer
    • O'Quigley, J., Pepe, M., Fisher, L. (1990). Continual reassessment method: A practical design for phase 1 clinical trials in cancer. Biometrics 46(1):33-48.
    • (1990) Biometrics , vol.46 , Issue.1 , pp. 33-48
    • O'Quigley, J.1    Pepe, M.2    Fisher, L.3
  • 15
    • 33746402001 scopus 로고    scopus 로고
    • Consistency of continual reassessment method under model misspecification
    • Shen, L. Z., O'Quigley, J. (1996). Consistency of continual reassessment method under model misspecification. Biometrika 83:395-405.
    • (1996) Biometrika , vol.83 , pp. 395-405
    • Shen, L.Z.1    O'Quigley, J.2
  • 16
    • 0031670630 scopus 로고    scopus 로고
    • Bayesian decision procedures based on logistic regression models for dose-finding studies
    • Whitehead, J., Williamson, D. (1998). Bayesian decision procedures based on logistic regression models for dose-finding studies. J. Biopharm. Statist. 8(3):445-467.
    • (1998) J. Biopharm. Statist. , vol.8 , Issue.3 , pp. 445-467
    • Whitehead, J.1    Williamson, D.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.